(Q43902800)

27 November 2017

Evaluation of the safety and efficacy of sibutramine, orlistat and metformin in the treatment of obesity (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

Gokcel A

1

1 reference

27 November 2017

Gumurdulu Y

2

1 reference

27 November 2017

Karakose H

3

1 reference

27 November 2017

Melek Ertorer E

4

1 reference

27 November 2017

Tanaci N

5

1 reference

27 November 2017

BascilTutuncu N

6

1 reference

27 November 2017

Guvener N

7

1 reference

27 November 2017

1 January 2002

1 reference

Diabetes, Obesity and Metabolism

27 November 2017

1 reference

27 November 2017

4

1 reference

27 November 2017

49-55

1 reference

27 November 2017

1

1 reference

Longitudinal studies to determine the effect of body fat rate reduction on blood pressure.

27 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Body Weight and Mortality among Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Weight gain as a risk factor for clinical diabetes mellitus in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Sibutramine produces dose-related weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

An overview of metformin in the treatment of type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Effect of metformin on food intake in obese subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Impairment of health and quality of life in people with large waist circumference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1463-1326.2002.00181.X

10.1046/J.1463-1326.2002.00181.X

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference